Vera Therapeutics Inc. (VERA)
NASDAQ: VERA
· Real-Time Price · USD
30.14
0.95 (3.25%)
At close: Oct 03, 2025, 3:59 PM
30.01
-0.43%
After-hours: Oct 03, 2025, 07:30 PM EDT
3.25% (1D)
| Bid | 28.52 |
| Market Cap | 1.92B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -218.28M |
| EPS (ttm) | -3.59 |
| PE Ratio (ttm) | -8.4 |
| Forward PE | -6.36 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 31 |
| Volume | 972,155 |
| Avg. Volume (20D) | 1,655,381.3 |
| Open | 29.39 |
| Previous Close | 29.19 |
| Day's Range | 29.09 - 30.62 |
| 52-Week Range | 18.53 - 51.61 |
| Beta | 1.23 |
| Ex-Dividend Date | n/a |
About VERA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VERA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VERA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+67.49%
Vera Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
8 months ago
-6.08%
Vera Therapeutics shares are trading lower. The company announced an exclusive license agreement with Stanford University for VT-109.
